October 16th Options Now Available For International Business Machines (IBM)

Two actionable IBM option strategies are presented: selling the $295 put (bid $28.60) would obligate purchase at $295 but nets a cost basis of $266.40 versus the current $296.61 share price, with a 58% analytical probability of expiring worthless and a YieldBoost of 9.69% (12.46% annualized). Alternatively, selling a covered call at the $305 strike (bid $29.95) against shares bought at $296.61 yields 12.93% if called at the October 16 expiration, with a 47% chance of expiring worthless and a 10.10% premium boost (12.98% annualized); implied vols are ~32–33% versus a 30% trailing 12-month volatility.

Analysis

Market structure: Short-term winners are option sellers and yield-seeking allocators able to harvest implied vol premium (IV_put=32%, IV_call=33% vs realized ~30%), plus brokers collecting commissions on elevated option flow. Long-term equity holders face capped upside if using covered calls; institutional delta-hedgers could create modest intraday flow around strikes (295/305) but no systemic supply shock. Cross-asset impact is muted; only scenario where options-induced delta-hedging affects Treasury basis is a large, concentrated roll of IBM options (>5% ADV open interest), currently unlikely.

Risk assessment: Tail risks include an unexpected negative earnings surprise, major contract loss, or macro shock that drops IBM >15% (>$250) before Oct 16, inflicting mark-to-market on put sellers. Timeframes: immediate — theta decay favors sellers (days–weeks); short-term to Oct 16 — option expiration risk; long-term (quarters) — fundamentals (AI services, software margins) determine direction. Hidden dependency: IV compression after positive catalysts can hurt put sellers and reduce covered-call carry; liquidity can vanish in gap moves.

Trade implications: For tactical income, cash-secured sale of IBM Oct16 $295 puts (collect $28.60, reserve $29,500 per contract) yields ~9.7% to expiry; size at 1–2% NAV per contract and cap downside with $295/$255 bull-put spread if unwilling to take assignment. Alternative buy-write: buy 100 IBM and sell Oct16 $305 call (collect $29.95) for ~12.9% gross to expiry; roll up if share >$305 or close if IV compresses >20% or stock < $250.

Contrarian angles: The market may underprice assignment aversion — many retail sellers will avoid cash-secured puts at this strike, keeping premium elevated; implied odds (58% expire worthless puts) likely overstate safety around earnings. Historical parallels (large-cap tech with buybacks) show stepwise re-rating after concrete AI contract wins; unintended consequence — heavy short-put interest could exacerbate downside gamma in a rapid selloff. Monitor open interest, IV skew, and upcoming earnings/M&A windows as 48–72 hour hard stop checkpoints.

Key Decisions for Investors

• Sell-to-open IBM Oct16 2026 $295 cash-secured put at $28.60 (collect $2,860, reserve $29,500 per contract). Position size 1%–2% of NAV (i.e., 1–2 contracts per $100k NAV). Set hard rule: buy-to-close if IBM < $250 or IV rises >50% vs today.
• Establish a buy-write: buy 100 IBM at market (~$296.61) and sell Oct16 $305 call for $29.95 to capture ~12.93% to expiry. Size to 1%–3% NAV, roll calls up only if share >$305 and delta <0.30, close if IV compresses >20% prior to expiry to lock gains.
• If assignment risk unacceptable, implement defined-risk bull put spread: sell Oct16 $295 / buy Oct16 $255 (width $40) to cap max loss at $40 less net credit; target net credit ≥$18 per spread (implying max loss ≈ $22 per share or $2,200 per spread).
• Monitor three triggers before adding: IBM quarterly results or material M&A within 30 days, IV skew change >5 vol points, or open interest jump >30% at 295/305 strikes — any trigger pauses new option-selling activity and prompts re-evaluation.